Virpi Glumoff

2.5k total citations
56 papers, 1.5k citations indexed

About

Virpi Glumoff is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Virpi Glumoff has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Virpi Glumoff's work include Neonatal Respiratory Health Research (14 papers), Tracheal and airway disorders (5 papers) and Immune Response and Inflammation (5 papers). Virpi Glumoff is often cited by papers focused on Neonatal Respiratory Health Research (14 papers), Tracheal and airway disorders (5 papers) and Immune Response and Inflammation (5 papers). Virpi Glumoff collaborates with scholars based in Finland, United States and Switzerland. Virpi Glumoff's co-authors include Mikko Hallman, Kirsi Harju, Marja Ojaniemi, Reija Paananen, Eero Vuorio, Kristiina Vuori, Mika Rämet, Raija Sormunen, Heli Salminen and Mikko Savontaus and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and Cancer Research.

In The Last Decade

Virpi Glumoff

53 papers receiving 1.5k citations

Peers

Virpi Glumoff
Mohamed S. Arredouani United States
Patty J. Lee United States
Katsuyuki Takeda United States
Anuk Das United States
Mohamed S. Arredouani United States
Virpi Glumoff
Citations per year, relative to Virpi Glumoff Virpi Glumoff (= 1×) peers Mohamed S. Arredouani

Countries citing papers authored by Virpi Glumoff

Since Specialization
Citations

This map shows the geographic impact of Virpi Glumoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virpi Glumoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virpi Glumoff more than expected).

Fields of papers citing papers by Virpi Glumoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virpi Glumoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virpi Glumoff. The network helps show where Virpi Glumoff may publish in the future.

Co-authorship network of co-authors of Virpi Glumoff

This figure shows the co-authorship network connecting the top 25 collaborators of Virpi Glumoff. A scholar is included among the top collaborators of Virpi Glumoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virpi Glumoff. Virpi Glumoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubaichuk, Kateryna, Tatjana Seitz, Ulrich Bergmann, et al.. (2024). Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via inositol polyphosphate-4-phosphatase type IIB. Oncogenesis. 13(1). 37–37. 4 indexed citations
2.
Arvonen, Miika, Outi Kuismin, Virpi Glumoff, et al.. (2024). Germline HAVCR2/TIM-3 Checkpoint Inhibitor Receptor Deficiency in Recurrent Autoinflammatory Myocarditis. Journal of Clinical Immunology. 44(3). 81–81. 4 indexed citations
3.
Mikkonen, Kirsi, Tytti Pokka, Heikki Rantala, et al.. (2024). Serum HMGB1 in febrile seizures. Epilepsy Research. 203. 107381–107381.
4.
Glumoff, Virpi, S. S. Räsänen, Airi Jartti, et al.. (2024). XMEN disease caused by the novel MAGT1 p.(Trp136*) mutation may present with neuropsychiatric symptoms. Journal of Neuroimmunology. 393. 578386–578386.
5.
Huuhtanen, Jani, Katriina Peltola, Tapio Lönnberg, et al.. (2023). Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma. Journal of Clinical Investigation. 133(6). 60 indexed citations
6.
Helander, Heli, Tytti Pokka, Heikki Rantala, et al.. (2022). Recurrent febrile seizures and serum cytokines: a controlled follow-up study. Pediatric Research. 93(6). 1574–1581. 5 indexed citations
7.
Mennerich, Daniela, Anatoly Samoylenko, Elitsa Y. Dimova, et al.. (2019). The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2. Cancer Research. 79(16). 4042–4056. 9 indexed citations
8.
Rajamäki, Kristiina, Salla Keskitalo, Mikko Seppänen, et al.. (2018). Haploinsufficiency of A20 impairs protein–protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. RMD Open. 4(2). e000740–e000740. 26 indexed citations
9.
Kubin, Minna E., Nina Kokkonen, R Palatsi, et al.. (2016). Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα – IL-23 – IL-17 Axis. Acta Dermato Venereologica. 97(4). 449–455. 15 indexed citations
10.
Glumoff, Virpi, et al.. (2013). TIM-family molecules in embryonic hematopoiesis: Fetal liver TIM-4lo cells have myeloid potential. Experimental Hematology. 42(3). 230–240. 6 indexed citations
11.
Hautala, Timo, Tarja Sironen, Nina Hautala, et al.. (2010). Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection. Annals of Medicine. 42(5). 344–351. 29 indexed citations
12.
Kristo, Aila, Matti Uhari, Tero Kontiokari, et al.. (2006). Nasal Middle Meatal Specimen Bacteriology as a Predictor of the Course of Acute Respiratory Infection in Children. The Pediatric Infectious Disease Journal. 25(2). 108–112. 20 indexed citations
13.
Reiser, Jakob, Virpi Glumoff, M. Kälin, & Urs A. Ochsner. (2005). Transfer and expression of heterologous genes in yeasts other than Saccharomyces cerevisiae. Advances in biochemical engineering, biotechnology. 43. 75–102. 6 indexed citations
14.
Harju, Kirsi, Marja Ojaniemi, Samuli Rounioja, et al.. (2005). Expression of Toll-Like Receptor 4 and Endotoxin Responsiveness in Mice during Perinatal Period. Pediatric Research. 57(5 Part 1). 644–648. 44 indexed citations
16.
Ojaniemi, Marja, et al.. (2003). Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophages. European Journal of Immunology. 33(3). 597–605. 279 indexed citations
17.
Glumoff, Virpi, et al.. (2003). Inflammatory and Anti-inflammatory Responsiveness of Surfactant Proteins in Fetal and Neonatal Rabbit Lung. Pediatric Research. 55(1). 55–60. 12 indexed citations
18.
Inkinen, Kaija, Ulla‐Stina Salminen, Paula Maasilta, et al.. (2001). Collagens I and III in a Porcine Bronchial Model of Obliterative Bronchiolitis. American Journal of Respiratory and Critical Care Medicine. 164(8). 1519–1525. 16 indexed citations
19.
Sakai, Keiko, László Hiripi, Virpi Glumoff, et al.. (2001). Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biology. 19(8). 761–767. 84 indexed citations
20.
Glumoff, Virpi, et al.. (1994). Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by Northern and in situ hybridization using species specific cDNA probes. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1219(3). 613–622. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026